Suppr超能文献

不同剂量及重复静脉注射肝素后,体力活动男性和久坐男性的肝素后血浆脂解活性

Postheparin plasma lipolytic activities in physically active and sedentary men after varying and repeated doses of intravenous heparin.

作者信息

Thompson P D, Kantor M A, Cullinane E M, Sady S P, Saritelli A, Herbert P N

出版信息

Metabolism. 1986 Nov;35(11):999-1004. doi: 10.1016/0026-0495(86)90035-1.

Abstract

We sought to determine the optimal dose of heparin for evaluating the activities of lipoprotein lipase (LPLA) and hepatic triglyceride hydrolase (HTGLA) in postheparin plasma. Nine physically active and ten sedentary men (age 30 +/- 5 yr, mean +/- SD) received 30, 50, 75, and 100 IU/kg of heparin in random order during a 2-week period. Based on all the samples, the average LPLA in the athletes was 43% higher (P less than 0.001) and HTGLA was 19% lower than in the untrained subjects (NS). The greatest LPLA was obtained after a heparin dose of 75 IU/kg, but LPLA after the three highest doses were not significantly different. There was also a dose effect on HTGLA (P less than 0.001) with greatest activities following doses of 75 and 100 IU/kg. Despite these dose effects, subjects maintained their rank order for both postheparin lipase activities regardless of the heparin dose. The only exception was for LPLA in the sedentary men probably because of lower LPLA and a smaller range of values. We also examined the effect of repeated daily injections of 75 IU/kg heparin on LPLA, HTGLA, and serum lipids. Repeated heparin administration on three consecutive days produced no significant effects on the apparent lipase activities. When all subjects were combined, HDL-cholesterol was increased over time (P less than 0.05) due to increases in both the HDL2 (P less than 0.05) and HDL3-cholesterol (NS) subfractions. Infusion of heparin or saline on three consecutive days into 18 additional men, however, had no effect on any lipid parameter.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们试图确定用于评估肝素后血浆中脂蛋白脂肪酶(LPLA)和肝甘油三酯水解酶(HTGLA)活性的肝素最佳剂量。9名体力活动较多的男性和10名久坐不动的男性(年龄30±5岁,均值±标准差)在2周内按随机顺序接受了30、50、75和100 IU/kg的肝素。基于所有样本,运动员的平均LPLA比未训练的受试者高43%(P<0.001),而HTGLA比未训练的受试者低19%(无显著性差异)。肝素剂量为75 IU/kg时LPLA最高,但最高的三个剂量后的LPLA无显著差异。HTGLA也存在剂量效应(P<0.001),75和100 IU/kg剂量后的活性最高。尽管有这些剂量效应,但无论肝素剂量如何,受试者肝素后脂肪酶活性的排名顺序保持不变。唯一的例外是久坐男性的LPLA,可能是因为其LPLA较低且数值范围较小。我们还研究了每天重复注射75 IU/kg肝素对LPLA、HTGLA和血脂的影响。连续三天重复给予肝素对表观脂肪酶活性无显著影响。当所有受试者合并时,由于HDL2(P<0.05)和HDL3胆固醇(无显著性差异)亚组分均增加,HDL胆固醇随时间增加(P<0.05)。然而,连续三天向另外18名男性输注肝素或生理盐水对任何脂质参数均无影响。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验